Effects of Aldosterone and Mineralocorticoid Receptor Blockade on Intracellular Electrolytes

被引:0
|
作者
Martin Wehling
机构
[1] University of Heidelberg,Institute of Clinical Pharmacology, Faculty for Clinical Medicine at Mannheim
[2] University of Heidelberg,Institute of Clinical Pharmacology, Faculty of Clinical Medicine Mannheim
来源
Heart Failure Reviews | 2005年 / 10卷
关键词
mineralocorticoids; intracellular electrolytes; rapid effects; second messengers;
D O I
暂无
中图分类号
学科分类号
摘要
Genomic mechanisms of mineralocorticoid action have been increasingly elucidated over the past four decades. In renal epithelia, the main effect is an increase in sodium transport through activation and de novo synthesis of epithelial sodium channels. This leads to increased concentrations of intracellular sodium activating sodium-potassium-ATPase molecules mainly at the basolateral membrane which extrude sodium back into the blood stream. In contrast, rapid steroid actions have been widely recognized only recently. The present article summarizes both traditional and rapid effects of mineralocorticoid hormones on intracellular electrolytes, e.g. free intracellular calcium in vascular smooth muscle cells as determined by fura 2 spectrofluorometry in single cultured cells from rat aorta. Latter effects are almost immediate, reach a plateau after only 3 to 5 minutes and are characterized by high specificity for mineralocorticoids versus glucocorticoids. The effect of aldosterone is blocked by neomycin and short-term treatment with phorbol esters but augmented by staurosporine, indicating an involvement of phospholipase C and protein kinase C. The Ca2+ effect appears to involve the release of intracellular Ca2+, as shown by the inhibitory effect of thapsigargin. This mechanism operates at physiological subnanomolar aldosterone concentrations and appears to result in rapid fine tuning of cardiovascular responsivity.
引用
收藏
页码:39 / 46
页数:7
相关论文
共 50 条
  • [41] Aldosterone-induced electrical remodeling and specific (eplerenone) versus unspecific (spironolactone) blockade of the mineralocorticoid receptor in vivo
    Dartsch, T.
    Fischer, R.
    Gapelyuk, A.
    Weiergraeber, M.
    Ladage, D.
    Reuter, H.
    Schneider, T.
    Schirdewan, A.
    Mueller-Ehmsen, J.
    Zobel, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 507 - 507
  • [42] Differential mortality risk prediction by aldosterone and cortisol in systolic heart failure with versus without mineralocorticoid receptor blockade
    Guder, G.
    Hammer, F.
    Brenner, S.
    Berliner, D.
    Deutschbein, T.
    Fassnacht, M.
    Allolio, A.
    Ertl, G.
    Angermann, C. E.
    Stoerk, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 285 - 285
  • [43] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Matthew J. Volk
    Andrew S. Bomback
    Philip J. Klemmer
    Current Hypertension Reports, 2011, 13 : 282 - 288
  • [44] A role for mineralocorticoid receptor blockade in the prevention of apoptosis
    Pitt, B
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) : 415 - 417
  • [45] Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor
    Rogerson, FM
    Dimopoulos, N
    Sluka, P
    Chu, S
    Curtis, AJ
    Fuller, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36305 - 36311
  • [46] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Bomback, Andrew S.
    Klemmer, Philip J.
    BLOOD PURIFICATION, 2012, 33 (1-3) : 119 - 124
  • [47] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Volk, Matthew J.
    Bomback, Andrew S.
    Klemmer, Philip J.
    CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 282 - 288
  • [48] Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats
    Takata, H.
    Takeda, Y.
    Zhu, A.
    Cheng, Y.
    Yoneda, T.
    Demura, M.
    Yagi, K.
    Karashima, S.
    Yamagishi, M.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02): : 155 - 162
  • [49] Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
    Rajesh Garg
    Gail K. Adler
    Current Hypertension Reports, 2015, 17
  • [50] The effects of mineralocorticoid receptor blockade with spironolactone on reactivity to novelty in marmosets (Callithrix jacchus)
    Smythe, JW
    Smith, AG
    Costall, B
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P269 - P269